AstraZeneca

Antibody-drug conjugates on the march
Pharmaforum
Thu, 01/30/20 - 10:41 am
antibody-drug conjugate
AstraZeneca
Daiichi Sankyo
Enhertu
Big pharma backed away from brain drugs. Is a return in sight?
BioPharma Dive
Wed, 01/29/20 - 11:55 pm
Big Pharma
Neuroscience
AstraZeneca
Bristol-Myers Squibb
GSK
Pfizer
Amgen
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
Xconomy
Mon, 01/27/20 - 10:57 am
Allergan
AbbVie
AstraZeneca
M&A
Nestle
After a brief break, AstraZeneca is back at divesting — handing off hypertension meds for $350M
Endpoints
Mon, 01/27/20 - 10:55 am
AstraZeneca
hypertension
Atnahs Pharma
Breast cancer approval in tow, AstraZeneca, Daiichi armed antibody scores in key gastric cancer study
Endpoints
Mon, 01/27/20 - 10:44 am
AstraZeneca
breast cancer
Daiichi Sankyo
trastuzumab deruxtecan
gastric cancer
AstraZeneca makes case for use of blood thinner Brilinta in stroke patients
Endpoints
Mon, 01/27/20 - 10:40 am
AstraZeneca
stroke
Brilinta
clinical trials
bloodthinners
After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune
Xconomy
Thu, 01/23/20 - 12:15 pm
AstraZeneca
MedImmune
AstraZeneca commits to being carbon negative by 2030
Pharmaforum
Wed, 01/22/20 - 10:55 am
AstraZeneca
climate change
carbon emissions
environmental concerns
Amid U.K. cutbacks, AstraZeneca plows $520M into manufacturing and R&D in France
Fierce Pharma
Tue, 01/21/20 - 11:38 pm
AstraZeneca
R&D
France
Brexit
UK
drug manufacturing
AstraZeneca’s Combination Treatment for HCC Snags Orphan Drug Designation
BioSpace
Mon, 01/20/20 - 10:16 pm
AstraZeneca
Imfinzi
orphan drugs
FDA
hepatocellular carcinoma
JPM: With Vascepa's U.S. expansion rolling, Amarin CEO holds off partner offers in EU
Fierce Pharma
Thu, 01/16/20 - 11:06 pm
Amarin
Vascepa
Epanova
AstraZeneca
Acasti
Europe
AZ and Merck, racing against Glaxo, nab Lynparza 'priority' boost in ovarian cancer
Fierce Pharma
Mon, 01/13/20 - 11:49 pm
AstraZeneca
Merck
GSK
Lynparza
ovarian cancer
FDA
priority review
Zejula
AstraZeneca's Epanova flunks key heart risk trial, giving Amarin's rival Vascepa a leg up
Fierce Pharma
Mon, 01/13/20 - 11:01 am
AstraZeneca
Amarin
Vascepa
Epanova
clinical trials
AstraZeneca gets in on RNA game with MiNA research collaboration
Endpoints
Tue, 01/7/20 - 10:39 am
AstraZeneca
RNA
MiNA
R&D
FDA Approves New Pancreatic Treatment Found To Double Time Patients Live Without Disease Progression
Forbes
Tue, 01/7/20 - 10:34 am
FDA
Lynparza
AstraZeneca
pancreatic cancer
AstraZeneca kicks off 2020 with double win in US and China
Pharmaforum
Mon, 01/6/20 - 10:23 am
AstraZeneca
FDA
Farxiga
heart failure
China
Lokelma
hyperkalemia
3 Blockbuster Cancer Drug Launches to Watch in 2020
Motley Fool
Thu, 01/2/20 - 11:57 pm
FDA
drug approvals
cancer
drug launches
AstraZeneca
Enhertu
Padcev
Seattle Genetics
BeiGene
Brukinsa
Corporate and regulatory developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:39 pm
Astellas
M&A
Qiagen
AstraZeneca
Bausch Health
BeiGene
Celyad
Immunomedics
Merck
Merck KGaA
Ono Pharmaceutical
Pfizer
Pharming
Xyphos Biosciences
FDA Approves AstraZeneca and Merck's Lynparza for Pancreatic Cancer
BioSpace
Mon, 12/30/19 - 05:39 pm
AstraZeneca
Merck
Lynparza
pancreatic cancer
FDA
FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing
Pharmaforum
Mon, 12/23/19 - 11:46 pm
FDA
AstraZeneca
Daiichi Sankyo
advanced breast cancer
Enhertu

Pages